Although lobectomy is considered the standard surgical treatment for the majority of patients with non-small-cell lung cancer (NSCLC), the operation project for patients with stage IA NSCLC (T1a, tumor diameter ≤2 cm) remains controversial. Sublobectomy is appropriate only in certain patients as many doctors consider it to be overtreatment. We evaluated the five-year overall survival rate of sublobectomy and lobectomy for stage IA NSCLC (T1a, tumor diameter ≤2 cm) through a meta-analysis.
Methods
The five-year overall survival rate (OS) of stage IA (T1a) NSCLC after sublobectomy (including wedge resection and segmentectomy) and lobectomy were compared. We also compared the OS of stage IA (T1a) NSCLC after segmentectomy and lobectomy. The log (hazard ratio, ln (HR)) and its standard error (SE) were used as the outcome measure for data combining.
Results
There were 12 eligible studies published between 1994 and 2013 in which the total number of participants was 18,720. When compared to lobectomy, there was a statistically significant difference of sublobectomy on OS of stage IA (T1a) NSCLC patients (HR 1.38; 95% confidence interval (95% CI), 1.19 to 1.61; P <0.0001). For the comparison between segmentectomy and lobectomy, there was also a statistically significant difference of segmentectomy alone on OS of stage IA (T1a) NSCLC patients (HR 1.48; 95% CI: 1.27 to 1.73; P <0.00001)
Conclusions
We have concluded that in stage IA (T1a) patients sublobectomy, including segmentectomy and wedge resection, causes a lower survival rate than lobectomy.
The online version of this article (doi:10.1186/1477-7819-12-138) contains supplementary material, which is available to authorized users.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YL participated in the literature searching and performed the statistical analysis, and drafted the manuscript. CH participated in the literature searching. HL and YC participated in the design of the study. SL conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
Background
With the wide use of high-resolution computed tomography (CT) and low-dose helical CT in lung cancer screening, an increasing number of non-small-cell lung cancers (NSCLCs) are diagnosed at the early T1 stage. Considering the relatively good prognosis of T1 stage NSCLC, many surgeons began to question the necessity of a total lobectomy in the management of patients with such small lesions [1‐3]. As an alternative, sublobectomy, including wedge resection and segmentectomy, reduces the length of surgery, thus resulting in fewer complications and shorter hospitalization time [4, 5]. This procedure is only acceptable in cases with a tumor size of less than 2 cm, according to the recommendation from the National Comprehensive Cancer Network (NCCN) Clinical Practice Guideline in Oncology for NSCLC, version 2.2013, however the outcome of sublobectomy is still controversial.
In 1995, the Lung Cancer Study Group (LCSG) compared the outcomes of sublobar with lobar resection in a randomized trial and demonstrated that patients with sublobar resection had a lower survival rate [6]. The same results have been published in some non-randomized trials [7], which examine a comparison between wedge resection alone and lobectomy. However, several other studies have demonstrated that limited resection was not inferior to lobectomy regarding prognosis in patients with small and peripheral NSCLC [8]. The results from the LCSG have been further challenged by several retrospective studies, which have suggested that limited resection might be equally effective in the treatment of stage IA (T1a) patients with a tumor size of less than 2 cm compared with lobectomy, particularly among elderly patients [9‐12].
Anzeige
To compare the outcome of sublobectomy and lobectomy, Nakamura et al. conducted a meta-analysis of published studies between 1970 and 2004 in 2005 [10]. The analysis indicated that the outcome of limited resection was comparable to lobectomy in patients with stage I lung cancer. Since then, several large clinical trial results have been published. In 2012, Fan et al. conducted another meta-analysis of published studies between 1990 and 2010 which indicated that for stage I patients, sublobectomy causes a lower survival rate than lobectomy, while for stage IA (T1a) patients, sublobectomy produces a similar survival rate to lobectomy [13]. Taking all these into consideration, we felt it necessary to reevaluate the efficacy of sublobectomy in patients with stage IA (T1a) NSCLC (tumor diameter ≤2 cm). We therefore collected the updated data from published studies between 1994 and 2013 and evaluated the effectiveness of sublobectomy compared to lobectomy for stage IA (T1a) NSCLC (tumor diameter ≤2 cm) through a meta-analysis of these studies.
Methods
Identification of studies
We searched PubMed using the strategy of (limited resection [Title/Abstract] OR (sublobar resection [Title/Abstract]) OR (segmentectomy [Title/Abstract]) OR (wedge resection [Title/Abstract]) AND (lung [Title/Abstract] OR pulmonary [Title/Abstract]) AND (cancer [Title/Abstract]) OR (carcinoma [Title/Abstract]) AND (lobectomy [Title/Abstract]). We also searched Embase by the strategy of ‘limited resection’: ab OR ‘sublobar resection’: ab OR segmentectomy: ab OR ‘wedge resection’: ab AND (lung: ab OR pulmonary: ab) AND (cancer: ab OR carcinoma: ab) AND lobectomy: ab. The citations of all retrieved articles were checked to identify any other potentially relevant publications. The studies in the search results were selected based on the inclusion and exclusion criteria. The inclusion criteria were: (i) outcomes of interest include overall survival rate (OS) (ii) articles were peer-reviewed, published, and original articles (iii) information was described in the article on how the hazard ratio (HR) and standard error (SE) can be calculated (iv) study subjects had to be limited to clinical stage IA (T1a) patients, (v) patients were divided into lobectomy and sublobectomy, (vi) if the enrolled patients were from the same institutions and in the same period, only the most recently published data would be enrolled into the study. The exclusion criteria were: (i) letters to editor, case reports, reviews, and non-English articles (ii) patients were divided into segmentectomy and wedge resection. In recent studies, the definition of sublobectomy includes the wedge resection and segmentectomy. Some of the studies analyzed the survival of patients after wedge resection or anatomic segmentectomy separately, whereas some studies studied only the survival after sublobectomy. We enrolled studies in which we could collect survival data after sublobectomy versus lobectomy to further analyze the outcomes of these results.
Statistical analysis
The log (hazard ratio, ln (HR)) and its standard error (SE) were used as the outcome measure for data combination [14, 15]. The SE was obtained as:
ln(upper 95% CI) - ln(lower 95% CI)/3:92
Anzeige
The ln (HR) and its SE were calculated from the reported data directly by HR and its 95% CI, or indirectly by reading and extracting from the Kaplan-Meier survival curve [5, 9, 12, 16‐24]. The heterogeneity of included studies was detected using the Cochran test. The publication bias was analyzed by Egger’s methods [25]. The evidence of asymmetry was based on P <1. Kaplan-Meier curves were read by Origin version 9 http://www.originlab.com. The data combining the test of heterogeneity was conducted and analyzed using Review Manager Version 5.1 http://www.cochrane.org/.
Results
The total number of studies obtained from the searches were 1342 from PubMed and Embase. According to the inclusion and exclusion criteria, there were 12 eligible studies published between 1994 and 2013 [5, 9, 12, 16‐24]. All of these studies were retrospective studies. The characteristics of all the included clinical trials are listed in Table 1. The size of the cohorts varied from 72 to 5626, with a total number of 18720 patients. In the analysis, the sublobectomy group was the experimental group and the lobectomy group was chosen as the reference. There were a total of 12 studies involved in the analysis that compared the impact of sublobectomy and lobectomy on OS of Stage IA (T1a) NSCLC patients. The combined HR of OS was 1.38 (95% CI, 1.19 to 1.61; P <0.0001). The sublobectomy group was inferior to patients treated with lobectomy. The Cochran tests for heterogeneity showed that tau2 = 0.03; chi2 = 30.57 df =13 (P = 0.004); I2 = 57%, which suggested significant inconsistency; and so we choose to use the random method instead random effects models (Figure 1). There was no significant publication bias detected at the section of analysis (Figure 2). Taking the age into consideration, we reasoned that the prognosis might be different in time periods. To minimize this deviation we excluded all data from before 2000 and made a future comparison. As a result, there were only three studies involved, and unfortunately, the outcome showed no statistical significance (HR 1.38; 95% CI, 0.95 to 2.00; P = 0.09) (Figure 3). In order to avoid the interaction between wedge resection and segmentectomy, we also made a further comparison between the segmentectomy group alone and the lobectomy group (Figure 4). The combined HR of OS was 1.48 (95% CI, 1.27 to 1.73; P <0.00001). The result is similar to that of the sublobectomy group. The Cochran tests for heterogeneity showed that tau2 = 0.00; chi2 = 3.97 df =6 (P =0.68); I2 = 0%.
The sublobectomy group did not distinguish between segmentectomy and wedge resection. In the study of Yendamuri et al. in 2013 [17], three groups of data in different time periods were compared.
×
×
×
×
Discussion
There are three original prospective randomized clinical trials about the comparison between sublobectomy and lobectomy. The earliest one is written by Ginsberg and Rubinstein in 1995 [6] and was excluded because the group division did not conform to our study. The other two trials were launched by The National Cancer Institute (NCI) (CALGB 140503) in 2008 [13] and The Japan Clinical Oncology Group with the West Japan Oncology Group (JCOG0802/WJOG4607L) in 2009 [26]; both comparing the survival of lobectomy and sublobectomy for small peripheral non-small-cell lung cancer (≤2 cm). Neither study has finished to date.
Before these studies publish their final results and conclusions, we used meta-analysis to combine current retrospective data. All the data included in our study were drawn from the retrospective studies. We found significant discrepancies among these studies for sample size, distribution of histological types, gender ratio, reasons for sublobectomy, and details of the operation. These differences might contribute to inter-study heterogeneity, therefore, the random model in RevMan was used for significant heterogeneities detection [27]. When considering the possible existence of publication bias among the enrolled studies, a test for publication bias was performed and no significant publication bias was detected after proper application of the above test.
The proper extent of pulmonary resection should achieve complete eradication of the malignancy and reduce the damage as much as possible. The operation project for patients with stage IA (T1a) NSCLC (tumor diameter ≤2 cm) remains controversial and has been under debate for several years.
We analyzed the impact of sublobectomy and lobectomy on the OS of NSCLC patients with stage IA (T1a) (tumors ≤2 cm). We found that the combined HR of OS was 1.38 (95% CI, 1.19 to 1.61; P <0.0001). The sublobectomy group was inferior to patients treated with the lobectomy. The segmentectomy group alone was similar to confirmed (HR 1.48, 95% CI, 1.27 to 1.73; P <0.00001). However, with recent data (data after 2000), we did not get the same results in the comparison between sublobectomy and lobectomy groups; there was no statistical significance (HR 1.38; 95% CI, 0.95 to 2.00; P = 0.09). Since there were only three studies in this comparison, we could not draw a definite conclusion, however, there could be a correlation between good prognosis and sublobectomy.
There are some limitations of this study:. (i) We could not collect and analyze data about the chemotherapy and radiotherapy information which might affect the survival of some patients. (ii) We consider the clinical stage more significant than the pathological one in choosing a surgical method, however, most of the retrospective studies did not describe clearly whether the stage was clinical or pathological; (iii) We think that the comparison in patients who can tolerate the lobectomy should be more powerful, however, most studies did not separate the lobectomy tolerance group and non-lobectomy tolerance group; (iv) Most studies did not take systematic or sampling lymphadenectomy into consideration, which could have an influence on the five-year survival rate; (v) Studies on the field of comparison between sublobectomy and lobectomy for stage IA (T1a) NSCLC have not taken the appearance on CT (pure solid, pure ground grass opacity (GGO), and part solid + GGO.) into consideration, which is quite important to the prognosis; and (vi) Retrospective studies could have some bias due to reasons which have been mentioned before.
Conclusions
The current meta-analysis disclosed that sublobectomy (including wedge resection and segmentectomy) causes lower OS in stage IA (T1a) NSCLC patients. We suggest that lobectomy is the best optimal choice, which is in line with the recommendation from National Comprehensive Cancer Network (NCCN) Clinical Practice Guideline in Oncology for NSCLC version 2.2013. Considering the heterogeneity among studies and all data from retrospective studies, the results of the meta-analysis should be interpreted with caution and the data of studies previously mentioned should be supplemented with a further analysis in the coming future.
Anzeige
Acknowledgements
We would like thanks to Zhichao Lai and Qianqian Pan for providing us assistance in the statistical calculation and data management respectively. This work was supported by the Key Grant Project of the Chinese Ministry of Education (NO.311037).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YL participated in the literature searching and performed the statistical analysis, and drafted the manuscript. CH participated in the literature searching. HL and YC participated in the design of the study. SL conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.
Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.
Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.
Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.
Update Chirurgie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.
Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.